/
/
/

Nureca Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)305.00
Volume (₹)520.00
High (₹)311.00
Upper Circuit320.25
Low (₹)303.00
Lower Circuit289.75
Prev Close305.00
52W High (₹)376.00
Price309.00
52W Low (₹)204.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)293.56 Cr
Div. Yield (%)0.00
PE Ratio61.67
Debt to Equity0.00
Price to Book1.09
Book Value189.44
EPS (TTM)4.99
Face Value10.00
ROE (%)1.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
LENSKARTNSE
MOLBIONSE
POLYMEDNSE
SMTNSE
QLINE-SMNSE
3BBLACKBIONSE
LAXMIDENTLNSE
OSELDEVICE-SMNSE
NURECA-BENSE
YASHOPTICS-SMNSE
LTP
1W Low
1W High
Market cap (₹)
681.1+2.9 (0.43%)
648.15
685
1,16,725Cr
1369.3+95.3 (7.48%)
1242.80
1388.90
15,579Cr
1534.3+84.8 (5.85%)
1443.40
1548.80
15,174Cr
463.75+1.05 (0.23%)
448.70
478.15
4,662Cr
529+16.25 (3.17%)
495
539.90
1,217Cr
1328.9+33.2 (2.56%)
1292
1382.60
1,145Cr
184.92+7.34 (4.13%)
176.77
187.65
1,002Cr
373+37.5 (11.18%)
330
380.40
666Cr
309+15.2 (5.17%)
288
311
294Cr
119+0.95 (0.80%)
111.05
119
279Cr

Key Highlights of Nureca Ltd Balance Sheet

Nureca Ltd balance sheet discloses shareholders' funds of ₹9.54Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹9.54Cr, and the reserves and surplus of the company is ₹167.62Cr.

The company has its non-current liabilities with total liabilities of ₹192.29Cr as of 2026-03-31.

The current liabilities are ₹15.91Cr as of 2026-03-31. At the same time, current assets are ₹111.58Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3.05Cr and tangible assets of ₹12.29Cr, provided in the Nureca Ltd financial statements.